Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Jason Zemansky
BofA

Jason Zemansky

Bank of America Securities
Wall Street Analyst
★★★☆☆
#2231
on 13Foresight · ranked by our own returns
42%
Success Rate
+0.9%
Average Return
45 of 106 calls profitable · +13.2% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 42% of Jason Zemansky's ratings turned a profit when each position was held for 1 year — averaging +0.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

123 Buy 57 Hold 10 Sell
Jason's Stock Coverage 22 ratings · 2026-11-12
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
BBIO
BridgeBio Pharma
 Oct 30, 2026 BUY Strong Buy
+26.0% avg upside
36 analysts
 — +6.1% ·
SNDX
Syndax Pharmaceuticals
 Oct 30, 2026 BUY Strong Buy
+155.4% avg upside
27 analysts
$23.00
68.42% Upside
 -30.5% ·
KURA
Kura Oncology
 Oct 30, 2026 BUY Strong Buy
+155.5% avg upside
27 analysts
$31.00
202.22% Upside
 -25.6% ·
LGND
Ligand Pharma
 Oct 30, 2026 BUY Strong Buy
-11.1% avg upside
16 analysts
$406.00
25.85% Upside
 -2.7% ·
BIIB
Biogen
 Oct 29, 2026 HOLD Strong Buy
+6.6% avg upside
53 analysts
$257.00
1.41% Upside
 +1.6% ·
TVTX
Travere Therapeutics
 Oct 28, 2026 BUY Strong Buy
+15.5% avg upside
22 analysts
$71.00
40.90% Upside
 +1.5% ·
ABOS
Acumen Pharmaceuticals
 Oct 26, 2026 BUY Strong Buy
+3291.3% avg upside
10 analysts
$8.00
3707.73% Upside
 -90.5% ·
RCUS
Arcus Biosciences
 Oct 20, 2026 HOLD Strong Buy
+98.9% avg upside
22 analysts
$29.00
59.48% Upside
 -20.8% ·
CYTK
Cytokinetics
 Oct 19, 2026 HOLD Strong Buy
+43.4% avg upside
36 analysts
$81.00
28.60% Upside
 -7.8% ·
MDGL
Madrigal Pharmaceuticals
 Oct 19, 2026 HOLD Strong Buy
+20.2% avg upside
34 analysts
$533.00
23.87% Upside
 -4.0% ·
EIKN
Eikon Therapeutics, Inc.
 Oct 19, 2026 BUY Strong Buy
+344.5% avg upside
6 analysts
$32.00
502.65% Upside
 -24.4% ·
INSM
Insmed
 Oct 12, 2026 BUY Strong Buy
+51.3% avg upside
37 analysts
$207.00
83.95% Upside
 +22.5% ·
RCKT
Rocket Pharmaceuticals
 Oct 07, 2026 BUY Buy
+546.4% avg upside
30 analysts
$10.00
309.92% Upside
 -2.2% ·
TYRA
Tyra Bioscience
 Sep 08, 2026 BUY Strong Buy
+107.4% avg upside
17 analysts
$39.00
85.05% Upside
 -20.9% ·
KROS
Keros Therapeutics
 Aug 11, 2026 HOLD Strong Buy
+116.6% avg upside
21 analysts
$17.00
54.08% Upside
 +1.8% ·
LYEL
Lyell Immunopharma
 Aug 11, 2026 SELL Strong Buy
+151.1% avg upside
12 analysts
$12.00
8.62% Upside
 -3.6% ·
IKT
Inhibikase Therapeutics
 Jul 27, 2026 BUY Strong Buy
+252.8% avg upside
9 analysts
$6.00
287.14% Upside
 -28.5% ·
HOWL
Werewolf Therapeutics
 Feb 17, 2026 BUY Strong Buy
+599.7% avg upside
8 analysts
$7.00
609.88% Upside
 +47.2% ·
BMRN
BioMarin Pharmaceutical
 Oct 30, 2024 BUY Strong Buy
+63.6% avg upside
52 analysts
 — -22.1% ·
OKUR
OnKure Therapeutics
 Mar 28, 2024 SELL Buy
+743.5% avg upside
13 analysts
$12.00
357.97% Upside
 +73.1% ·
KLRS
Kalaris Therapeutics
 Dec 26, 2023 SELL Buy
+528.1% avg upside
13 analysts
$1.00
50.65% Downside
 +37.0% ·
QTTB
Q32 Bio
 Nov 17, 2023 HOLD Strong Buy
+523.8% avg upside
28 analysts
 — +226.9% ·
🔒 17 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Jason Zemansky — Frequently Asked Questions
How accurate are Jason Zemansky's stock ratings?
Based on the calls 13Foresight could measure, about 42% of Jason's ratings were profitable over a one-year hold, with an average return of +0.8% per rating, or -0.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Jason ranked on 13Foresight?
Jason Zemansky is currently ranked #2231 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Jason cover?
Jason most recently has ratings on BBIO, SNDX, KURA, LGND, BIIB, TVTX, ABOS, RCUS, CYTK, MDGL, EIKN, INSM and 10 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.